Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression
Devarati Mitra(Brigham and Women's Hospital), B. Ashleigh Guadagnolo(The University of Texas MD Anderson Cancer Center), Priyadharsini Nagarajan(The University of Texas MD Anderson Cancer Center), Rodabe N. Amaria(The University of Texas MD Anderson Cancer Center), Anuja Jhingran(The University of Texas MD Anderson Cancer Center), Ahsan Farooqi(The University of Texas MD Anderson Cancer Center), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Joel Ho(The University of Texas MD Anderson Cancer Center), Michael Frumovitz(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Morgan A. Farr(The University of Texas MD Anderson Cancer Center), Andrew J. Bishop(The University of Texas MD Anderson Cancer Center)
Cited by 14
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876